Evaluation of parameters of the small airways and their changes under treatment with ciclesonide (320 mcg once daily) versus placebo in patients with asthma

Trial Profile

Evaluation of parameters of the small airways and their changes under treatment with ciclesonide (320 mcg once daily) versus placebo in patients with asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Ciclesonide (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 May 2012 Company (Takeda Global Research and Development Center) added to the associations field as reported by ClinicalTrials.gov record.
    • 20 May 2007 Results have been reported.
    • 19 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top